Literature DB >> 10594790

Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis.

F S Shihab1, T F Andoh, A M Tanner, H Yi, W M Bennett.   

Abstract

UNLABELLED: Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis.
BACKGROUND: Chronic cyclosporine (CsA) nephrotoxicity is characterized by interstitial fibrosis, tubular dropout, and loss of cellularity in areas of fibrosis. Apoptosis was found to play a role in CsA-induced fibrosis. We evaluated the role of the death genes p53, Bax, and Fas-L (ligand), survival gene Bcl-2, interleukin-converting enzyme (ICE), and caspase-3.
METHODS: Salt-depleted rats were administered CsA 15 mg/kg/day or vehicle (VH) and were sacrificed at 7 or 28 days. Apoptosis was detected by TdT-mediated dUTP-biotin nick end labeling assay. p53 and Bax expressions were evaluated by Northern and Western blot analysis. Fas-L and Bcl-2 expressions were evaluated by immunofluorescence. In addition to ICE mRNA, caspase-3 enzymatic activity was assayed.
RESULTS: Although no differences were seen at one week, apoptosis-positive cells increased with CsA at four weeks (P < 0.05) and correlated with tubular atrophy and interstitial fibrosis (r = 0.8, P < 0.05). CsA induced the expression of p53 (P < 0.05) and Bax (P < 0.01) and decreased that of Bcl-2 (P < 0.05). CsA up-regulated Fas-L expression (P < 0.001). ICE mRNA and caspase-3 activity were also increased (P < 0.01). The changes occurred as early as one week and remained statistically significant at four weeks.
CONCLUSIONS: Specific apoptotic genes are increased in chronic CsA nephrotoxicity. The balance favors the induction of apoptosis. Increased apoptosis could explain the tubular dropout and loss of cellularity with fibrosis. This then may impair the ability of the tubulointerstitium to remodel. Apoptosis could also contribute to some of CsA immunosuppressive effects on activated lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10594790     DOI: 10.1046/j.1523-1755.1999.00794.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

Review 1.  Current status of immunosuppression in liver transplantation.

Authors:  Narendra S Choudhary; Sanjiv Saigal; Rajat Shukla; Hardik Kotecha; Neeraj Saraf; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2013-06-03

2.  Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis.

Authors:  A Fornoni; H Li; A Foschi; G E Striker; L J Striker
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

3.  Apoptosis contributes to amphotericin B-induced nephrotoxicity.

Authors:  D E Varlam; M M Siddiq; L A Parton; H Rüssmann
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

4.  IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis.

Authors:  Michiya Shinozaki; Junichi Hirahashi; Tatiana Lebedeva; Foo Y Liew; David J Salant; Ruth Maron; Vicki Rubin Kelley
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

5.  Insights into the effects of hyperlipoproteinemia on cyclosporine A biodistribution and relationship to renal function.

Authors:  Hamidreza Montazeri Aliabadi; Tara J Spencer; Parvin Mahdipoor; Afsaneh Lavasanifar; Dion R Brocks
Journal:  AAPS J       Date:  2006-10-27       Impact factor: 4.009

6.  Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts.

Authors:  Maarten Naesens; Evelyne Lerut; Hylke de Jonge; Boudewijn Van Damme; Yves Vanrenterghem; Dirk R J Kuypers
Journal:  J Am Soc Nephrol       Date:  2009-09-17       Impact factor: 10.121

7.  DNA double-strand breaks induced intractable glomerular fibrosis in renal allografts.

Authors:  Yuki Matsui; Yumi Sunatani; Norifumi Hayashi; Kazuaki Okino; Yuki Okushi; Kiyotaka Mukai; Hiroki Adachi; Hideki Yamaya; Kuniyoshi Iwabuchi; Hitoshi Yokoyama
Journal:  Clin Exp Nephrol       Date:  2015-10-06       Impact factor: 2.801

8.  Comparison of early and late conversion of sirolimus in experimental model of chronic cyclosporine nephropathy.

Authors:  Jin Young Kim; Jung Yeon Ghee; Sun Woo Lim; Shang Guo Piao; Byung Ha Chung; Hye Eun Yoon; Hyeon Seok Hwang; Bum Soon Choi; Jin Kim; Chul Woo Yang
Journal:  J Korean Med Sci       Date:  2012-01-27       Impact factor: 2.153

Review 9.  Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients.

Authors:  Sepideh Zununi Vahed; Mohammadreza Ardalan; Nasser Samadi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2015-02-21

Review 10.  Established and newly proposed mechanisms of chronic cyclosporine nephropathy.

Authors:  Hye Eun Yoon; Chul Woo Yang
Journal:  Korean J Intern Med       Date:  2009-06-08       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.